Literature DB >> 6187274

Immunocytochemical comparison of neurofibrillary tangles in senile dementia of Alzheimer type, progressive supranuclear palsy, and postencephalitic parkinsonism.

S H Yen, D S Horoupian, R D Terry.   

Abstract

Antiserum raised against a two-cycle-purified human brain microtubule fraction that binds specifically to tangles of senile dementia of the Alzheimer type was tested on the subthalamus, basis pontis, and midbrain sections of two patients with progressive supranuclear palsy. Tangles composed of 15 nm straight fibers in these areas showed positive immunolabeling with the antiserum. The labeling tangles appeared as a fibrous meshwork in neuronal cell bodies and occasionally in short segments of axons. Corresponding sections of brains obtained from patients with idiopathic parkinsonism, striatonigral degeneration, and olivopontocerebellar atrophy treated with the same antiserum did not display peroxidase products. Only in the elderly subjects and patients with postencephalitic parkinsonism did the periaqueductal gray and median raphe show occasional cells that reacted positively with the antiserum. Tangles in the substantia nigra of patients with postencephalitic parkinsonism were also recognized by the antiserum. The results suggest that the two morphologically distinct neurofibrillary tangles share their immunological properties with components present in microtubule fractions of normal brain.

Entities:  

Mesh:

Year:  1983        PMID: 6187274     DOI: 10.1002/ana.410130211

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

1.  Filaments of Lewy bodies contain insoluble cytoskeletal elements.

Authors:  P G Galloway; P Mulvihill; G Perry
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

2.  Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles.

Authors:  C Bancher; H Lassmann; H Budka; I Grundke-Iqbal; K Iqbal; G Wiche; F Seitelberger; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

3.  Immunochemical demonstration of tropomyosin in the neurofibrillary pathology of Alzheimer's disease.

Authors:  P G Galloway; P Mulvihill; S Siedlak; M Mijares; M Kawai; H Padget; R Kim; G Perry
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

4.  Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy.

Authors:  M Pérez; J M Valpuesta; E M de Garcini; C Quintana; M Arrasate; J L López Carrascosa; A Rábano; J García de Yébenes; J Avila
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

5.  Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement.

Authors:  P Vermersch; Y Robitaille; L Bernier; A Wattez; D Gauvreau; A Delacourte
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Neurofibrillary tangles in senile dementia of the Alzheimer type share an antigenic determinant with intermediate filaments of the vimentin class.

Authors:  S H Yen; F Gaskin; S M Fu
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

7.  Pure akinesia: an atypical manifestation of progressive supranuclear palsy.

Authors:  H Matsuo; H Takashima; M Kishikawa; I Kinoshita; M Mori; M Tsujihata; S Nagataki
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-05       Impact factor: 10.154

8.  Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer's disease or progressive supranuclear palsy.

Authors:  T Uchihara; K Mitani; H Mori; H Kondo; M Yamada; K Ikeda
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Monoclonal antibodies to Alzheimer neurofibrillary tangles. 2. Demonstration of a common antigenic determinant between ANT and neurofibrillary degeneration in progressive supranuclear palsy.

Authors:  D W Dickson; Y Kress; A Crowe; S H Yen
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

10.  Progressive supranuclear palsy: a brief personalized history.

Authors:  R B Daroff
Journal:  Yale J Biol Med       Date:  1987 Mar-Apr
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.